Logo
x

Search

Subscribe Now

All Posts by Date

Genome & Company Signs a Clinical Trial Agreement with Merck KGaA and Pfizer to Evaluate the Combination Therapy

Genome & Company Signs a Clinical Trial Agreement with Merck KGaA and Pfizer to Evaluate the Combination Therapy

  • January 15, 2020
Astellas' Xospata (gilteritinib) Receives Health Canada Approval for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

Astellas' Xospata (gilteritinib) Receives Health Canada Approval for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mut...

  • January 15, 2020
ViiV Healthcare's Dovato (dolutegravir/lamivudine) Receives MHLW's Approval to Treat HIV 1 Infection

ViiV Healthcare's Dovato (dolutegravir/lamivudine) Receives MHLW's Approval to Treat HIV 1 Infection

  • January 15, 2020
Insilico Collaborates with Pfizer to Explore Novel Data and AI System for Target Discovery

Insilico Collaborates with Pfizer to Explore Novel Data and AI System for Target Discovery

  • January 15, 2020
JAMP Signs an Agreement with Alvotech to Commercialize Five Biosimilars in Canada

JAMP Signs an Agreement with Alvotech to Commercialize Five Biosimilars in Canada

  • January 15, 2020
Alexion to Initiate P-III CHAMPION-ALS Study Evaluating Ultomiris (ravulizumab) in Amyotrophic Lateral Sclerosis

Alexion to Initiate P-III CHAMPION-ALS Study Evaluating Ultomiris (ravulizumab) in Amyotrophic Lateral Sclerosis

  • January 15, 2020
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.